Biological characteristics, biosafety prevention and control strategies for the 2022 multi-country outbreak of monkeypox  

作　　者：Chudan Liang Jun Qian Linna Liu 

机构地区：[1]Zhongshan School of Medicine,Sun Yat-sen University,Guangzhou 510080,China [2]Key Laboratory of Tropical Disease Control(Sun Yat-sen University),Ministry of Education,Guangzhou 510030,China [3]Guangzhou Eighth People's Hospital,Guangzhou Medical University,Guangzhou 510440,China

出　　处：《Biosafety and Health》2022年第6期376-385,共10页生物安全与健康（英文）

基　　金：supported by the Science and Technology Planning Project of Guangdong Province(2021B1212040017);the Science and Technology Innovation Project of the Ministry of Education(2022ZL01);the Sun Yat-sen University Founded Program(2022_76220_B21127).

摘　　要：Monkeypox is a zoonotic disease caused by the monkeypox virus(MPXV),which is a potential biological warfare agent of bioterrorism and poses the greatest threat to the world’s public biosafety and health after variola virus(VARV).While the coronavirus disease 2019(COVID-19)pandemic has not ended yet,monkeypox is spreading menacingly.The first case of monkeypox in a nonendemic country was confirmed on May 6^(th),2022,while the first imported case from Asia was found on June 21^(st).There were more than 16 thousand reported cases as of July 23^(rd),the day the World Health Organization(WHO)declared the global monkeypox outbreak a public health emergency of international concern(PHEIC)at the same level as smallpox and COVID-19;while there were more than 53 thousand cases as of September 1^(st).Therefore,we will propose relevant biosafety prevention and control strategies after analyzing the etiology of the 2022 multi-country monkeypox outbreak from the biological feature,transmissibility,epidemic,and variability of MPXV.

关 键 词：Monkeypox virus Re-emerging infectious disease Biological characteristics Biosafety strategy 

分 类 号：R511[医药卫生—内科学] R184[医药卫生—临床医学]